Moderna (MRNA) has had the highest return since June 12, 2026 by a US stock with a market cap of $50B+, returning 343.6%.
| ASSET | % RETURN |
|---|---|
Moderna (MRNA) | 343.62% |
Atlassian (TEAM) | 113.71% |
Veeva Systems Inc Class A (VEEV) | 92.59% |
Natera (NTRA) | 85.2% |
Marathon Petroleum (MPC) | 70.92% |
Phillips 66 (PSX) | 60.09% |
Valero Energy (VLO) | 59.35% |
Accenture (ACN) | 56.4% |
Regeneron Pharmaceuticals (REGN) | 51.52% |
Thomson Reuters Corporation Common Shares (TRI) | 49.32% |
Thermo Fisher Scientific (TMO) | 46% |
Crowdstrike (CRWD) | 45.04% |
SAP SE ADR (SAP) | 44.67% |
Palantir Technologies (PLTR) | 40.63% |
Cheniere Energy (LNG) | 40.2% |
Salesforce (CRM) | 39.35% |
Equinor ASA ADR (EQNR) | 38.46% |
Gilead Sciences (GILD) | 36.98% |
ConocoPhillips (COP) | 35.72% |
Becton Dickinson and (BDX) | 34.55% |
Microsoft (MSFT) | 33.59% |
Takeda Pharmaceutical Co Ltd ADR (TAK) | 33.49% |
Palo Alto Networks (PANW) | 32.11% |
Travelers Companies (TRV) | 31.97% |
Automatic Data Processing (ADP) | 31.91% |